April 29, 2020 / 5:44 AM / a month ago

BRIEF-Kimia Biosciences Gets Nod To Manufacture New API

April 29 (Reuters) - Kimia Biosciences Ltd:

* GRANTED PERMISSION TO MANUFACTURING AND MARKETING OF NEW ACTIVE PHARMACEUTICAL INGREDIENT AZELNIDIPINE DRUG

* PERMISSION BY INDIA’S CENTRAL DRUGS STANDARD CONTROL ORGANIZATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below